(Q39732794)

English

Treatment with insulin glargine (Lantus) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Treatment with insulin glargine (Lantus) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells (English)

1 reference

Europe PubMed Central

14 September 2017

type-1 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Doris Mayer

1

1 reference

Europe PubMed Central

14 September 2017

Ernst Chantelau

2

1 reference

Europe PubMed Central

14 September 2017

publication date

1 May 2010

1 reference

Europe PubMed Central

14 September 2017

Archives of Physiology and Biochemistry

1 reference

Europe PubMed Central

14 September 2017

116

1 reference

Europe PubMed Central

14 September 2017

2

1 reference

Europe PubMed Central

14 September 2017

73-78

1 reference

Europe PubMed Central

14 September 2017

Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

No evidence for accumulation of insulin glargine (LANTUS): a multiple injection study in patients with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Gastric cancer in very young adults: apropos four patients and a review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I.

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Comparison of 11 human insulin assays: implications for clinical investigation and research.

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Proliferative effect of Apidra (insulin glulisine), a rapid-acting insulin analogue on mammary epithelial cells

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Insulin analogues: too much noise about small benefits

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Does diabetes therapy influence the risk of cancer?

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

1 reference

https://api.crossref.org/works/10.3109%2F13813451003631439

21 January 2018

Identifiers

10.3109/13813451003631439

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39732794&oldid=2089199026"